Atropisomeric Diaryl Ethers
University of Manchester, UK
Helsinki, Uusimaa, Finland
Dr. Christopher P Worrall joined Nanoform as Vice President in May 2021. He is an expert in the area of crystallization and physicochemical modification, having spent the last 14 years specializing in the pharmaceutical solid form, including 13 years with Pharmorphix. Dr. Worrall has been involved in the development of 8 commercial pharmaceutical products and is an inventor on numerous patents in the areas of liquid crystals, organic semi-conductors, and pharmaceutical solid form. Prior to 2008, he held positions at SAFC and Merck KGaA focusing on developing organic syntheses for GMP production of active pharmaceutical ingredients and liquid crystalline display materials. He earned his PhD in synthetic organic chemistry from the University of Manchester, UK, and has multiple publications in the areas of atropisomerism and enantioselective synthesis.
Disclosure information not submitted.
Wednesday, October 19, 2022
11:00 AM – 12:00 PM ET